Translational prediction of first-in-human pharmacokinetics and pharmacodynamics of janagliflozin, a selective SGLT2 inhibitor, using allometric scaling, dedrick and PK/PD modeling methods-Reference-Cited by-同舟云学术

Translational prediction of first-in-human pharmacokinetics and pharmacodynamics of janagliflozin, a selective SGLT2 inhibitor, using allometric scaling, dedrick and PK/PD modeling methods

Published:2020-04 Issue: Volume:147 Page:105281
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Song Ling,Yao Xueting^ORCID,Liu Yang,Zhong Wen,Jiang Ji,Liu Hongzhong,Zhou Huimin,Shi Chongtie,Zong Kaiqi,Wang Chong,Ma Chuanxiang,Liu Dongyang,Hu Pei

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference20 articles.

1. Pharmacokinetics, pharmacodynamics, and safety of single-dose canagliflozin in healthy Chinese subjects;Chen;Clin. Ther.,2015

2. Physiological parameters in laboratory animals and humans;Davies;Pharm. Res.,1993

3. Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus;Grewal;Mini Rev. Med. Chem.,2014

4. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American diabetes association and the European association for the study of diabetes;Inzucchi;Diabetes Care,2015

5. Clinical implication of SGLT2 inhibitors in type 2 diabetes;Kim;Arch. Pharm. Res.,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of quantitative pharmacology analysis to support early clinical development of oncology drugs: dose selection;Xenobiotica;2024-08-08

2. Pharmacological Treatment of Diabetes Mellitus: An Overview of New Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Diabetes Mellitus;Journal of Endocrinology and Metabolism;2024-06

3. Computer simulations in pharmacokinetics;Physico-Chemical Aspects of Dosage Forms and Biopharmaceutics;2024

4. Combined translational pharmacometrics approach to support the design and conduct of the first‐in‐human study of DWP16001;British Journal of Clinical Pharmacology;2023-09-22

5. SGLT2 Inhibitors as Potential Anticancer Agents;Biomedicines;2023-06-30